Results 111 to 120 of about 4,527 (138)
Minimally Invasive Glaucoma Surgery. [PDF]
Dtsch Arztebl IntVoykov B, Prokosch V, Lübke J.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Ophthalmology Glaucoma, 2023
HORIZON trials have reported the medium- and long-term outcomes of the Hydrus microstent. However, outside of randomized clinical trials, outcomes beyond 24 months have not been previously reported. Here, we examine the 3-year outcomes of the Hydrus microstent with cataract surgery outside of a randomized clinical trial setting.Single-surgeon ...
Rabea Kassem +2 more
exaly +3 more sources
HORIZON trials have reported the medium- and long-term outcomes of the Hydrus microstent. However, outside of randomized clinical trials, outcomes beyond 24 months have not been previously reported. Here, we examine the 3-year outcomes of the Hydrus microstent with cataract surgery outside of a randomized clinical trial setting.Single-surgeon ...
Rabea Kassem +2 more
exaly +3 more sources
Cataract Extraction and Hydrus Microstent Implantation
2021In patients with both cataract and glaucoma, the ophthalmologist may choose to treat both conditions in the same operative encounter. Combined cataract extraction, IOL implantation, and Hydrus microstent insertion offers the patient visual rehabilitation, better control of glaucoma, and the benefit of not having to return to the OR for a second ...
Jeb Alden Ong +2 more
exaly +2 more sources
Expert Review of Medical Devices, 2023
Minimally invasive glaucoma surgeries (MIGS) are now a consolidated reality in many surgical units. The Hydrus Microstent is one of several MIGS devices bypassing trabecular outflow and had excellent results over the years. This article aims to review the key features of the Hydrus Microstent in terms of design, efficacy, and safety.The present review ...
Antonio Maria Fea +2 more
exaly +3 more sources
Minimally invasive glaucoma surgeries (MIGS) are now a consolidated reality in many surgical units. The Hydrus Microstent is one of several MIGS devices bypassing trabecular outflow and had excellent results over the years. This article aims to review the key features of the Hydrus Microstent in terms of design, efficacy, and safety.The present review ...
Antonio Maria Fea +2 more
exaly +3 more sources
A Case of Uveitis-Glaucoma-Hyphema Syndrome Related to a Hydrus Microstent
Journal of Glaucoma, 2023Uveitis-Glaucoma-Hyphema (UGH) syndrome is characterized by episodes of anterior chamber inflammation, elevated intraocular pressure and hyphema. It is caused by a mechanical chafing of the iris or ciliary body typically by a malpositioned intraocular lens. We present a rare case of UGH syndrome related to the insertion of a Hydrus Microstent.
Tyler M, Kaplan, Arthur J, Sit
openaire +2 more sources
Three-Year Results of Hydrus Microstent With Phacoemulsification.
Ophthalmology Glaucoma, 2019Abstract We report the 3-year IOP efficacy of the implantation of the Schlemm’s canal Hydrus® Microstent (Ivantis®) combined with phacoemulsification versus phacoemulsification ...
Panagiotis Laspas +2 more
exaly +6 more sources
Journal of the National Medical Association, 2020
To report a case of a patient with mixed mechanism glaucoma and a clear lens who was successfully surgically treated with combination cataract extraction, goniosynechiolysis and the Hydrus stent.A 59-year-old Afro-Latino woman with a history of mixed mechanism glaucoma. She was taking latanoprost OU QHS.
Daniel Laroche, Aaron Brown, Chester NG
openaire +2 more sources
To report a case of a patient with mixed mechanism glaucoma and a clear lens who was successfully surgically treated with combination cataract extraction, goniosynechiolysis and the Hydrus stent.A 59-year-old Afro-Latino woman with a history of mixed mechanism glaucoma. She was taking latanoprost OU QHS.
Daniel Laroche, Aaron Brown, Chester NG
openaire +2 more sources
Journal of Glaucoma, 2023
Précis: Compared with phacoemulsification and microstent alone, we observed that phacoemulsification with combined microstent and canaloplasty resulted in a significantly greater reduction in glaucoma medications while maintaining similar rates of intraocular pressure reduction and low complications.
Anna Dickinson +9 more
openaire +2 more sources
Précis: Compared with phacoemulsification and microstent alone, we observed that phacoemulsification with combined microstent and canaloplasty resulted in a significantly greater reduction in glaucoma medications while maintaining similar rates of intraocular pressure reduction and low complications.
Anna Dickinson +9 more
openaire +2 more sources
Ophthalmology GlaucomaTo evaluate the efficacy and safety of the Hydrus Microstent in conjunction with cataract surgery in patients with normal tension glaucoma (NTG) with minimum 12-month follow-up.Retrospective cohort study.Normal tension glaucoma eyes having Hydrus with cataract surgery and cataract-only controls.Glaucoma was staged by the Hodapp-Parrish-Anderson ...
Debbie S Kuo
exaly +3 more sources
Canadian Journal of OphthalmologyTo report 5-year real-world outcomes of Hydrus Microstent implantation with cataract surgery (Hydrus+CS) in mild to severe open-angle glaucoma (OAG).A retrospective, consecutive case series.OAG eyes undergoing Hydrus+CS with 5-year follow-up.The primary outcome was surgical success using various criteria based on intraocular pressure (IOP) thresholds (≤
Ali Salimi, Paul Harasymowycz
exaly +3 more sources